Scale Personalized Patient Engagement from Trial to Real World
Pharma is increasingly expected to deliver more than treatment alone.
Patients, providers, and healthcare systems expect personalized support, continuous engagement, and real-world evidence that extends beyond clinical trials.
The challenge is not the lack of ideas.
The challenge is operationalizing and scaling patient engagement programs across clinical partners, patient populations, and geographies.
DataMentor provides the infrastructure that enables pharma organizations and their clinical partners to design, deploy, refine, and scale Patient Intervention Models across the lifecycle—from clinical studies to real-world patient support.
Challenges We Help Solve
Valuable Clinical Expertise Remains Difficult to Operationalize
Clinical partners often develop innovative approaches to improving adherence, lifestyle change, self-management, and patient support. These approaches frequently remain local initiatives and never reach broader patient populations.
Patient Engagement Programs Are Difficult to Scale
Many engagement initiatives rely on fragmented technologies, custom development projects, or manual processes. This creates operational complexity and limits scalability.
Real-World Evidence and Patient Engagement Remain Disconnected
Patient engagement generates valuable insights. However, these insights are often isolated from research, evidence generation, and continuous program improvement.
Innovation Cycles Are Too Slow
Launching and refining patient engagement initiatives often takes months or years. Organizations need a faster path from concept to measurable patient impact.
How DataMentor Helps
Enable Patient Intervention Models
DataMentor allows pharma organizations and clinical partners to transform intervention concepts into deployable Patient Intervention Models. These models can include engagement strategies, monitoring logic, behavioral support mechanisms, escalation workflows, and personalized interventions—while remaining fully configurable and continuously improvable.
- Engagement strategies
- Monitoring logic
- Behavioral support mechanisms
- Escalation workflows
- Personalized interventions
Deploy Across Clinical Partners
Patient Intervention Models can be deployed across hospitals, clinics, research sites, digital health programs, and patient support initiatives using a shared infrastructure.
- Hospitals
- Clinics
- Research sites
- Digital health programs
- Patient support initiatives
Support Continuous Learning
Real-world data, adherence signals, participant feedback, and outcome measures can continuously inform intervention refinement. This creates a learning cycle that improves programs over time.
Connect Engagement and Evidence
Patient engagement activities become part of a broader evidence-generation framework through PROMs, EMA, wearables, nutritional profiling, longitudinal follow-up, and intervention tracking—allowing engagement and evidence generation to reinforce one another.
- PROMs
- EMA
- Wearables
- Nutritional profiling
- Longitudinal follow-up
- Intervention tracking
Scale What Works
Validated intervention models can be reused and adapted across indications, countries, healthcare systems, and clinical partners—without rebuilding infrastructure.
- Indications
- Countries
- Healthcare systems
- Clinical partners
Typical Use Cases
Obesity and Metabolic Health Programs
Support lifestyle change, adherence, and long-term engagement.
Patient Support Programs
Deliver personalized patient journeys around therapy initiation and ongoing treatment.
Real-World Evidence Programs
Combine engagement, real-world data capture, and evidence generation within one infrastructure.
Digital Companion Programs
Extend product value through data-driven patient support and continuous interaction.
Precision Health Initiatives
Deploy intervention models that adapt to patient context, behavior, and outcomes.
DataMentor does not define the intervention.
Your clinicians, researchers, physicians, and patient support teams do.
DataMentor provides the infrastructure that enables those interventions to be:
across patients, programs, clinical partners, and geographies.